Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 20/20 | 0.64 |
| ▸ | MC3R | P41968 | 6/20 | 0.62 |
| ▸ | MC1R | Q01726 | 5/20 | 0.62 |
| ▸ | MC5R | P33032 | 5/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13063961 | 1.00 | MC4R (0.64) | MC4RMC3RMC1RMC5R | |
| SCHEMBL10307976 | 0.97 | MC4R (0.67) | MC4RMC3RMC1RMC5R | |
| SCHEMBL19473781 | 0.97 | MC4R (0.67) | MC4RMC3RMC1RMC5R | |
| SCHEMBL13063967 | 0.97 | MC4R (0.67) | MC4RMC3RMC1RMC5R | |
| SCHEMBL10308009 | 0.97 | MC4R (0.66) | MC4RMC3RMC1RMC5R | |
| SCHEMBL10307900 | 0.97 | MC4R (0.66) | MC4RMC3RMC1RMC5R | |
| SCHEMBL10307962 | 0.97 | MC4R (0.66) | MC4RMC3RMC1RMC5R | |
| SCHEMBL10308020 | 0.97 | MC4R (0.66) | MC4RMC3RMC1RMC5R | |
| SCHEMBL10308005 | 0.97 | MC4R (0.66) | MC4RMC3RMC1RMC5R | |
| SCHEMBL19473838 | 0.97 | MC4R (0.66) | MC4RMC3RMC1RMC5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10632171-B2 | Melanocortin receptor-specific peptides | PALATIN TECHNOLOGIES, INC. (US) | 2020-04-28 | — | — | US | disclosed |
| US-20190216887-A1 | Melanocortin Receptor-Specific Peptides | PALATIN TECHNOLOGIES INC (US) | 2019-07-18 | — | — | US | disclosed |
| US-10179804-B2 | Melanocortin receptor-specific peptides | PALATIN TECHNOLOGIES, INC. (US) | 2019-01-15 | — | — | US | disclosed |
| EP-2440227-B1 | MELANOCORTIN RECEPTOR-SPECIFIC PEPTIDES | PALATIN TECHNOLOGIES INC (US) | 2017-10-18 | — | — | EP | disclosed |
| US-20160318977-A1 | Melanocortin Receptor-Specific Peptides | PALATIN TECHNOLOGIES INC (US) | 2016-11-03 | — | — | US | disclosed |
| US-9458201-B2 | Melanocortin receptor-specific heptapeptides | PALATIN TECHNOLOGIES, INC. (US) | 2016-10-04 | — | — | US | disclosed |
| US-20140357575-A1 | Melanocortin Receptor-Specific Heptapeptides | PALATIN TECHNOLOGIES INC (US) | 2014-12-04 | — | — | US | disclosed |
| US-8846601-B2 | Melanocortin receptor-specific peptides | PALATIN TECHNOLOGIES, INC. (US) | 2014-09-30 | — | — | US | disclosed |
| US-20120178701-A1 | Melanocortin Receptor-Specific Peptides | PALATIN TECHNOLOGIES, INC. (US) | 2012-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10179804-B2 | Melanocortin receptor-specific peptides | MC1R, MC3R, MC5R | MC4R 4/4885MC3R 2/4885MC1R 1/4885 |
| US-20140357575-A1 | Melanocortin Receptor-Specific Heptapeptides | MC5R, MC1R, MC3R | MC4R 5/4885MC3R 3/4885MC1R 2/4885 |
| US-20190216887-A1 | Melanocortin Receptor-Specific Peptides | MC1R, MC3R, MC4R | MC4R 3/4885MC3R 2/4885MC1R 1/4885 |
| US-20160318977-A1 | Melanocortin Receptor-Specific Peptides | MC1R, MC3R, MC5R | MC4R 4/4885MC3R 2/4885MC1R 1/4885 |
| US-10632171-B2 | Melanocortin receptor-specific peptides | MC1R, MC3R, MC4R | MC4R 3/4885MC3R 2/4885MC1R 1/4885 |
| US-20120178701-A1 | Melanocortin Receptor-Specific Peptides | MC1R, MC3R, MC5R | MC4R 4/4885MC3R 2/4885MC1R 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.